The benefits of continuous flow manufacturing are significant and numerous and those benefits grow with each technological breakthrough and methodological advance.

The benefits of continuous flow manufacturing are significant and numerous and those benefits grow with each technological breakthrough and methodological advance.

Through the combination of process optimization, modularization and automation, our continuous flow process can improve the productivity and quality of pharmaceuticals by increasing process robustness, reducing chemical waste, and making it easier and safer to handle unstable chemicals.

Future-ready CDMOs are making the technology and facility investments needed to further transform supply chain security, and are already pursuing initiatives that will support cost optimization and enhance supply chain agility as a competitive advantage.

A look at an end‑to‑end partner with expertise, technologies, and capacity to advance complex programs from early research to commercial supply, with deeper capabilities available in the full asset.

Explore how integrated flow technologies are accelerating safer, cleaner, and more efficient pharmaceutical production. See how advanced process design, scalable equipment, and real‑world breakthroughs are redefining modern manufacturing and enabling faster, more sustainable pathways from development to delivery.

Asymchem has comprehensive biotransformation capabilities and extensive experience harnessing our expertise to satisfy customer needs, providing greener processes that don’t just reduce supply and cost risks, but environmental impact as well.

Our experts support clients with pre-formulation, formulation, process and analytical development, as well as production and registration. We’ve worked on a range of both oral solid dosage and injectable projects for clients over the years.

Asmychem’s Chemical Macromolecule Division (CMMD) can support traditional peptides, pseudopeptides, peptide+linker, peptide-drug conjugates, polymer-drug conjugates, and other highly active peptide molecules.

Asymchem is a leading global contract development and manufacturing organization focused on developing practical and sustainable processes for both clinical phase and commercial scale projects in pharmaceutical & biopharmaceutical industries, with the inspections of NMPA, USFDA and other global regulatory authorities.

Our expert team of 120 process chemists and 50 analytical chemists deliver process chemistry experience, formulation, analytical expertise and regulatory insight to meet your oligonucleotide and peptide needs.

Asymchem offers a superior mix of CDMO solutions today while continually driving new innovations to give you a greater advantage tomorrow. See what our KNOW-HOW can do for your development needs.